Pharmagene raises 40.8 million

Pharmagene (Royston, U.K.), a functional genomics company based on tissue typing, raised 40.8 million ($61.9 million) in an IPO of 14.3 million shares at 285p. UBS Warburg is the sponsor, financial ad...